Table 1. Demographics and baseline characteristics (in numbers (%) if not otherwise specified).
| Age (median, years) | 53 (range 29–74) |
|---|---|
| Gender | |
| Male | 16 (50) |
| Female | 16 (50) |
| WHO performance status | |
| 0 | 11 (34) |
| 1 | 21 (66) |
| Tumour type | |
| Sarcoma | 15 (47) |
| Chondrosarcoma | 2 (6) |
| Leiomyosarcoma | 2 (6) |
| Liposarcoma | 2 (6) |
| Ewing sarcoma | 2 (6) |
| Pleomorphic sarcoma | 2 (6) |
| Other sarcoma types | 5 (16) |
| Carcinoma of unknown primary tumour | 3 (9) |
| Neuroendocrine carcinoma | 2 (6) |
| Non-small-cell lung cancer | 2 (6) |
| Melanoma (uveal and mucosal) | 2 (6) |
| Miscellaneousa | 8 (26) |
| Previous non-hormonal systemic anticancer treatment | |
| 0 | 5 (16) |
| 1 | 18 (56) |
| 2 | 5 (16) |
| 3 | 2 (6) |
| 4 | 2 (6) |
Abbreviation: WHO=World Health Organisation.
a
Bile duct carcinoma, breast cancer, adenoid cystic carcinoma, endometrial cancer, urothelial cancer, pancreatic cancer, chordoma and cervical carcinoma; for all the cases n=1.